Search

Stephen L. Rawlings

Examiner (ID: 18470, Phone: (571)272-0836 , Office: P/1643 )

Most Active Art Unit
1643
Art Unit(s)
1642, 1643, 1646
Total Applications
1483
Issued Applications
633
Pending Applications
153
Abandoned Applications
701

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10234966 [patent_doc_number] => 20150119961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-30 [patent_title] => 'Malignant Tumor Heat Therapy Kit Comprising Anti-Regulatory T Cell Antibody and Magnetic Fine Particles and Heat Therapy Method Thereof' [patent_app_type] => utility [patent_app_number] => 14/576852 [patent_app_country] => US [patent_app_date] => 2014-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3593 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14576852 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/576852
Malignant Tumor Heat Therapy Kit Comprising Anti-Regulatory T Cell Antibody and Magnetic Fine Particles and Heat Therapy Method Thereof Dec 18, 2014 Abandoned
Array ( [id] => 10491244 [patent_doc_number] => 20150376265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-31 [patent_title] => 'ANTIBODY COMPOSITIONS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 14/577991 [patent_app_country] => US [patent_app_date] => 2014-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 38541 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 54 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14577991 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/577991
ANTIBODY COMPOSITIONS AND METHODS OF USE Dec 18, 2014 Abandoned
Array ( [id] => 10290707 [patent_doc_number] => 20150175706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'Novel Antibodies Against Cancer Target Block Tumor Growth, Angiogenesis and Metastatis' [patent_app_type] => utility [patent_app_number] => 14/571801 [patent_app_country] => US [patent_app_date] => 2014-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 15815 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14571801 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/571801
Novel Antibodies Against Cancer Target Block Tumor Growth, Angiogenesis and Metastatis Dec 15, 2014 Abandoned
Array ( [id] => 10240482 [patent_doc_number] => 20150125478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-07 [patent_title] => 'NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS' [patent_app_type] => utility [patent_app_number] => 14/562156 [patent_app_country] => US [patent_app_date] => 2014-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 46092 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14562156 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/562156
Immunotherapy against several tumors including neuronal and brain tumors Dec 4, 2014 Issued
Array ( [id] => 10354977 [patent_doc_number] => 20150239983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-27 [patent_title] => 'HIGH AFFINITY ANTI-PROSTATE STEM CELL ANTIGEN (PSCA) ANTIBODIES FOR CANCER TARGETING AND DETECTION' [patent_app_type] => utility [patent_app_number] => 14/562269 [patent_app_country] => US [patent_app_date] => 2014-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 12114 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14562269 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/562269
High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection Dec 4, 2014 Issued
Array ( [id] => 11351525 [patent_doc_number] => 20160370265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-22 [patent_title] => 'METHOD FOR ISOLATING EXOSOMES' [patent_app_type] => utility [patent_app_number] => 15/100931 [patent_app_country] => US [patent_app_date] => 2014-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7847 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15100931 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/100931
METHOD FOR ISOLATING EXOSOMES Dec 2, 2014 Abandoned
Array ( [id] => 10283426 [patent_doc_number] => 20150168424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'IGFBP2 Biomarker' [patent_app_type] => utility [patent_app_number] => 14/556402 [patent_app_country] => US [patent_app_date] => 2014-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25508 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14556402 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/556402
IGFBP2 Biomarker Nov 30, 2014 Abandoned
Array ( [id] => 9900935 [patent_doc_number] => 20150056135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-26 [patent_title] => 'Treatment of Proliferative Disorders Using Antibodies to PSMA' [patent_app_type] => utility [patent_app_number] => 14/537002 [patent_app_country] => US [patent_app_date] => 2014-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17019 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14537002 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/537002
Treatment of Proliferative Disorders Using Antibodies to PSMA Nov 9, 2014 Abandoned
Array ( [id] => 10254989 [patent_doc_number] => 20150139986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-21 [patent_title] => 'ILT3 BINDING MOLECULES AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 14/527834 [patent_app_country] => US [patent_app_date] => 2014-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23903 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14527834 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/527834
ILT3 BINDING MOLECULES AND USES THEREFOR Oct 29, 2014 Abandoned
Array ( [id] => 11348911 [patent_doc_number] => 20160367651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-22 [patent_title] => 'T CELL INDUCING VACCINE CONTAINING AN INTEREPITOPE SEQUENCE THAT PROMOTES ANTIGEN PRESENTATION' [patent_app_type] => utility [patent_app_number] => 15/026841 [patent_app_country] => US [patent_app_date] => 2014-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10502 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15026841 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/026841
T CELL INDUCING VACCINE CONTAINING AN INTEREPITOPE SEQUENCE THAT PROMOTES ANTIGEN PRESENTATION Sep 30, 2014 Abandoned
Array ( [id] => 11888033 [patent_doc_number] => 09758584 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-12 [patent_title] => 'Biological materials related to CXCR7' [patent_app_type] => utility [patent_app_number] => 14/501426 [patent_app_country] => US [patent_app_date] => 2014-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 41446 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14501426 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/501426
Biological materials related to CXCR7 Sep 29, 2014 Issued
Array ( [id] => 10208408 [patent_doc_number] => 20150093398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-02 [patent_title] => 'Methods and Compositions for Treating or Preventing Cancer' [patent_app_type] => utility [patent_app_number] => 14/487659 [patent_app_country] => US [patent_app_date] => 2014-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19666 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14487659 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/487659
Methods and Compositions for Treating or Preventing Cancer Sep 15, 2014 Abandoned
Array ( [id] => 9910182 [patent_doc_number] => 20150065383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-05 [patent_title] => 'METHOD FOR DETECTING CERVICAL DYSPLASIA' [patent_app_type] => utility [patent_app_number] => 14/480546 [patent_app_country] => US [patent_app_date] => 2014-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16645 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14480546 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/480546
Method for detecting cervical dysplasia Sep 7, 2014 Issued
Array ( [id] => 10593466 [patent_doc_number] => 09314537 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-19 [patent_title] => 'SPARC binding ScFcs' [patent_app_type] => utility [patent_app_number] => 14/451858 [patent_app_country] => US [patent_app_date] => 2014-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 17612 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14451858 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/451858
SPARC binding ScFcs Aug 4, 2014 Issued
Array ( [id] => 10586683 [patent_doc_number] => 09308279 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-12 [patent_title] => 'SPARC binding ScFvs' [patent_app_type] => utility [patent_app_number] => 14/451008 [patent_app_country] => US [patent_app_date] => 2014-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 17582 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14451008 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/451008
SPARC binding ScFvs Aug 3, 2014 Issued
Array ( [id] => 10990399 [patent_doc_number] => 20160187343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-30 [patent_title] => 'COMPOSITIONS AND METHODS FOR IDENTIFYING A RISK OF CANCER IN A SUBJECT' [patent_app_type] => utility [patent_app_number] => 14/908822 [patent_app_country] => US [patent_app_date] => 2014-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23403 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14908822 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/908822
COMPOSITIONS AND METHODS FOR IDENTIFYING A RISK OF CANCER IN A SUBJECT Jul 30, 2014 Abandoned
Array ( [id] => 10966984 [patent_doc_number] => 20140370016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-18 [patent_title] => 'SPARC BINDING SCFVS' [patent_app_type] => utility [patent_app_number] => 14/448696 [patent_app_country] => US [patent_app_date] => 2014-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 17547 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14448696 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/448696
SPARC binding ScFcs Jul 30, 2014 Issued
Array ( [id] => 11415252 [patent_doc_number] => 09562070 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-07 [patent_title] => 'Induction of tumor immunity by variants of folate binding protein' [patent_app_type] => utility [patent_app_number] => 14/339797 [patent_app_country] => US [patent_app_date] => 2014-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 39710 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14339797 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/339797
Induction of tumor immunity by variants of folate binding protein Jul 23, 2014 Issued
Array ( [id] => 11785014 [patent_doc_number] => 09394359 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-19 [patent_title] => 'Methods and agents for the diagnosis and treatment of hepatocellular carcinoma' [patent_app_type] => utility [patent_app_number] => 14/336441 [patent_app_country] => US [patent_app_date] => 2014-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 153 [patent_figures_cnt] => 186 [patent_no_of_words] => 31796 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14336441 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/336441
Methods and agents for the diagnosis and treatment of hepatocellular carcinoma Jul 20, 2014 Issued
Array ( [id] => 10979999 [patent_doc_number] => 20160176943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-23 [patent_title] => 'NOVEL ALTERNATIVE SPLICE TRANSCRIPTS FOR MHC CLASS I RELATED CHAIN ALPHA (MICA) AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/902615 [patent_app_country] => US [patent_app_date] => 2014-07-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 32349 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14902615 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/902615
NOVEL ALTERNATIVE SPLICE TRANSCRIPTS FOR MHC CLASS I RELATED CHAIN ALPHA (MICA) AND USES THEREOF Jul 3, 2014 Abandoned
Menu